Pegaspargase Injection

Product description

It is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in the treatment of acute lymphoblastic leukemia.

Strength: 5ml:3750IU; 2ml:1500IU

It has been approved by CFDA.

Read more

Specifications

Categories Finished Dosage FormsInjectables; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers